TFPI and cancer: The controversial role of the thrombotic pathway in cancer progression, as it promotes cancer when active [2], [3], yet appears to generate untreatable forms of cancer when subsequently inhibited [11], [12], led us to focus our efforts on defining a role for TFPI1 expression in the establishment of DOX resistance.